nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprostone—SLCO3A1—Methotrexate—systemic scleroderma	0.135	0.189	CbGbCtD
Dinoprostone—SLCO1C1—Methotrexate—systemic scleroderma	0.0863	0.121	CbGbCtD
Dinoprostone—SLCO1B1—Mycophenolate mofetil—systemic scleroderma	0.07	0.098	CbGbCtD
Dinoprostone—SLCO1A2—Prednisone—systemic scleroderma	0.0593	0.0831	CbGbCtD
Dinoprostone—SLC22A6—Captopril—systemic scleroderma	0.0571	0.0801	CbGbCtD
Dinoprostone—SLC22A11—Methotrexate—systemic scleroderma	0.0445	0.0624	CbGbCtD
Dinoprostone—SLC22A7—Methotrexate—systemic scleroderma	0.0424	0.0594	CbGbCtD
Dinoprostone—ABCC4—Methotrexate—systemic scleroderma	0.0414	0.0581	CbGbCtD
Dinoprostone—CYP1A2—Pentoxifylline—systemic scleroderma	0.0389	0.0545	CbGbCtD
Dinoprostone—CYP1A2—Leflunomide—systemic scleroderma	0.0371	0.052	CbGbCtD
Dinoprostone—SLCO1A2—Methotrexate—systemic scleroderma	0.0297	0.0417	CbGbCtD
Dinoprostone—SLCO1B1—Methotrexate—systemic scleroderma	0.0281	0.0393	CbGbCtD
Dinoprostone—SLC22A8—Methotrexate—systemic scleroderma	0.0259	0.0363	CbGbCtD
Dinoprostone—SLC22A6—Methotrexate—systemic scleroderma	0.018	0.0253	CbGbCtD
Dinoprostone—PTGIR—pulmonary artery—systemic scleroderma	0.0131	0.119	CbGeAlD
Dinoprostone—PTGIR—artery—systemic scleroderma	0.00487	0.0441	CbGeAlD
Dinoprostone—PTGIR—endothelium—systemic scleroderma	0.00411	0.0372	CbGeAlD
Dinoprostone—PTGIR—blood vessel—systemic scleroderma	0.00379	0.0343	CbGeAlD
Dinoprostone—PTGER4—connective tissue—systemic scleroderma	0.00326	0.0295	CbGeAlD
Dinoprostone—SLC51B—digestive system—systemic scleroderma	0.00323	0.0292	CbGeAlD
Dinoprostone—SLC51B—tendon—systemic scleroderma	0.00307	0.0278	CbGeAlD
Dinoprostone—PTGER4—smooth muscle tissue—systemic scleroderma	0.00298	0.027	CbGeAlD
Dinoprostone—PTGER3—connective tissue—systemic scleroderma	0.00276	0.025	CbGeAlD
Dinoprostone—SLC51B—lung—systemic scleroderma	0.00269	0.0244	CbGeAlD
Dinoprostone—PTGER3—smooth muscle tissue—systemic scleroderma	0.00252	0.0229	CbGeAlD
Dinoprostone—HPGDS—connective tissue—systemic scleroderma	0.00238	0.0216	CbGeAlD
Dinoprostone—PTGER4—digestive system—systemic scleroderma	0.00235	0.0213	CbGeAlD
Dinoprostone—SLC51A—digestive system—systemic scleroderma	0.00231	0.0209	CbGeAlD
Dinoprostone—PTGER2—tendon—systemic scleroderma	0.00228	0.0207	CbGeAlD
Dinoprostone—PTGER4—tendon—systemic scleroderma	0.00224	0.0203	CbGeAlD
Dinoprostone—SLC51A—tendon—systemic scleroderma	0.0022	0.0199	CbGeAlD
Dinoprostone—PTGFR—smooth muscle tissue—systemic scleroderma	0.00202	0.0183	CbGeAlD
Dinoprostone—PTGER2—lung—systemic scleroderma	0.002	0.0181	CbGeAlD
Dinoprostone—PTGER3—digestive system—systemic scleroderma	0.00199	0.018	CbGeAlD
Dinoprostone—PTGER4—lung—systemic scleroderma	0.00197	0.0178	CbGeAlD
Dinoprostone—PTGIR—connective tissue—systemic scleroderma	0.00194	0.0176	CbGeAlD
Dinoprostone—SLC51A—lung—systemic scleroderma	0.00193	0.0175	CbGeAlD
Dinoprostone—PTGIR—smooth muscle tissue—systemic scleroderma	0.00178	0.0161	CbGeAlD
Dinoprostone—HPGDS—digestive system—systemic scleroderma	0.00172	0.0156	CbGeAlD
Dinoprostone—CYP11A1—connective tissue—systemic scleroderma	0.00168	0.0152	CbGeAlD
Dinoprostone—PTGER3—lung—systemic scleroderma	0.00166	0.0151	CbGeAlD
Dinoprostone—HPGDS—tendon—systemic scleroderma	0.00164	0.0148	CbGeAlD
Dinoprostone—SLCO2A1—skin of body—systemic scleroderma	0.00153	0.0139	CbGeAlD
Dinoprostone—PTGFR—tendon—systemic scleroderma	0.00152	0.0137	CbGeAlD
Dinoprostone—HPGDS—lung—systemic scleroderma	0.00144	0.013	CbGeAlD
Dinoprostone—PTGIR—digestive system—systemic scleroderma	0.0014	0.0127	CbGeAlD
Dinoprostone—SLC22A11—digestive system—systemic scleroderma	0.00137	0.0124	CbGeAlD
Dinoprostone—SLC22A7—digestive system—systemic scleroderma	0.00134	0.0121	CbGeAlD
Dinoprostone—PTGFR—lung—systemic scleroderma	0.00133	0.012	CbGeAlD
Dinoprostone—SLC22A2—digestive system—systemic scleroderma	0.00119	0.0108	CbGeAlD
Dinoprostone—SLCO3A1—tendon—systemic scleroderma	0.00118	0.0107	CbGeAlD
Dinoprostone—PTGIR—lung—systemic scleroderma	0.00117	0.0106	CbGeAlD
Dinoprostone—SLCO2A1—tendon—systemic scleroderma	0.00117	0.0106	CbGeAlD
Dinoprostone—SLCO4A1—digestive system—systemic scleroderma	0.00113	0.0102	CbGeAlD
Dinoprostone—CYP19A1—connective tissue—systemic scleroderma	0.00109	0.00989	CbGeAlD
Dinoprostone—ABCC5—tendon—systemic scleroderma	0.00107	0.00967	CbGeAlD
Dinoprostone—SLCO3A1—lung—systemic scleroderma	0.00103	0.00937	CbGeAlD
Dinoprostone—SLCO2A1—lung—systemic scleroderma	0.00103	0.00928	CbGeAlD
Dinoprostone—SLCO1B1—digestive system—systemic scleroderma	0.000993	0.00899	CbGeAlD
Dinoprostone—SLCO4A1—lung—systemic scleroderma	0.000943	0.00854	CbGeAlD
Dinoprostone—ABCC5—lung—systemic scleroderma	0.000938	0.00849	CbGeAlD
Dinoprostone—SLCO2B1—digestive system—systemic scleroderma	0.000879	0.00795	CbGeAlD
Dinoprostone—SLCO2B1—tendon—systemic scleroderma	0.000836	0.00757	CbGeAlD
Dinoprostone—SLCO1A2—digestive system—systemic scleroderma	0.000809	0.00732	CbGeAlD
Dinoprostone—ABCC4—digestive system—systemic scleroderma	0.000778	0.00704	CbGeAlD
Dinoprostone—ABCC4—tendon—systemic scleroderma	0.000741	0.0067	CbGeAlD
Dinoprostone—SLCO2B1—lung—systemic scleroderma	0.000734	0.00664	CbGeAlD
Dinoprostone—SLCO1A2—lung—systemic scleroderma	0.000675	0.00611	CbGeAlD
Dinoprostone—ABCC4—lung—systemic scleroderma	0.00065	0.00588	CbGeAlD
Dinoprostone—CYP1A2—digestive system—systemic scleroderma	0.000529	0.00479	CbGeAlD
Dinoprostone—Vaginal inflammation—Methotrexate—systemic scleroderma	0.000514	0.00292	CcSEcCtD
Dinoprostone—Shock—Captopril—systemic scleroderma	0.000513	0.00292	CcSEcCtD
Dinoprostone—Back pain—Leflunomide—systemic scleroderma	0.000509	0.00289	CcSEcCtD
Dinoprostone—Tachycardia—Captopril—systemic scleroderma	0.000509	0.00289	CcSEcCtD
Dinoprostone—Pain—Mometasone—systemic scleroderma	0.000507	0.00288	CcSEcCtD
Dinoprostone—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.000507	0.00288	CcSEcCtD
Dinoprostone—Muscle spasms—Leflunomide—systemic scleroderma	0.000506	0.00288	CcSEcCtD
Dinoprostone—Acute coronary syndrome—Mycophenolate mofetil—systemic scleroderma	0.0005	0.00284	CcSEcCtD
Dinoprostone—Myocardial infarction—Mycophenolate mofetil—systemic scleroderma	0.000497	0.00283	CcSEcCtD
Dinoprostone—Vision blurred—Leflunomide—systemic scleroderma	0.000496	0.00282	CcSEcCtD
Dinoprostone—Asthenia—Pentoxifylline—systemic scleroderma	0.000493	0.00281	CcSEcCtD
Dinoprostone—Tension—Mycophenolic acid—systemic scleroderma	0.000493	0.0028	CcSEcCtD
Dinoprostone—Hypotension—Captopril—systemic scleroderma	0.000487	0.00277	CcSEcCtD
Dinoprostone—Back pain—Mycophenolic acid—systemic scleroderma	0.000486	0.00276	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Mometasone—systemic scleroderma	0.000485	0.00276	CcSEcCtD
Dinoprostone—Vaginal infection—Methotrexate—systemic scleroderma	0.000485	0.00276	CcSEcCtD
Dinoprostone—Muscle spasms—Mycophenolic acid—systemic scleroderma	0.000483	0.00274	CcSEcCtD
Dinoprostone—Flushing—Lisinopril—systemic scleroderma	0.000482	0.00274	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.000475	0.0027	CcSEcCtD
Dinoprostone—Myalgia—Azathioprine—systemic scleroderma	0.000475	0.0027	CcSEcCtD
Dinoprostone—Arthralgia—Azathioprine—systemic scleroderma	0.000475	0.0027	CcSEcCtD
Dinoprostone—Vision blurred—Mycophenolic acid—systemic scleroderma	0.000473	0.00269	CcSEcCtD
Dinoprostone—Angiopathy—Lisinopril—systemic scleroderma	0.000471	0.00268	CcSEcCtD
Dinoprostone—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000471	0.00268	CcSEcCtD
Dinoprostone—Tremor—Mycophenolic acid—systemic scleroderma	0.00047	0.00267	CcSEcCtD
Dinoprostone—Body temperature increased—Mometasone—systemic scleroderma	0.000469	0.00267	CcSEcCtD
Dinoprostone—Abdominal pain—Mometasone—systemic scleroderma	0.000469	0.00267	CcSEcCtD
Dinoprostone—Paraesthesia—Captopril—systemic scleroderma	0.000468	0.00266	CcSEcCtD
Dinoprostone—Chills—Lisinopril—systemic scleroderma	0.000466	0.00265	CcSEcCtD
Dinoprostone—Dyspnoea—Captopril—systemic scleroderma	0.000465	0.00264	CcSEcCtD
Dinoprostone—Arrhythmia—Lisinopril—systemic scleroderma	0.000464	0.00264	CcSEcCtD
Dinoprostone—Cough—Leflunomide—systemic scleroderma	0.000459	0.00261	CcSEcCtD
Dinoprostone—Dizziness—Pentoxifylline—systemic scleroderma	0.000455	0.00259	CcSEcCtD
Dinoprostone—Hypertension—Leflunomide—systemic scleroderma	0.000454	0.00258	CcSEcCtD
Dinoprostone—Pharyngitis—Mycophenolate mofetil—systemic scleroderma	0.000452	0.00257	CcSEcCtD
Dinoprostone—Syncope—Mycophenolic acid—systemic scleroderma	0.00045	0.00256	CcSEcCtD
Dinoprostone—Myalgia—Leflunomide—systemic scleroderma	0.000448	0.00255	CcSEcCtD
Dinoprostone—Chest pain—Leflunomide—systemic scleroderma	0.000448	0.00255	CcSEcCtD
Dinoprostone—Arthralgia—Leflunomide—systemic scleroderma	0.000448	0.00255	CcSEcCtD
Dinoprostone—Tension—Lisinopril—systemic scleroderma	0.000444	0.00252	CcSEcCtD
Dinoprostone—CYP1A2—lung—systemic scleroderma	0.000441	0.004	CbGeAlD
Dinoprostone—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.000441	0.00251	CcSEcCtD
Dinoprostone—Cough—Mycophenolic acid—systemic scleroderma	0.000438	0.00249	CcSEcCtD
Dinoprostone—Back pain—Lisinopril—systemic scleroderma	0.000437	0.00249	CcSEcCtD
Dinoprostone—Vomiting—Pentoxifylline—systemic scleroderma	0.000437	0.00249	CcSEcCtD
Dinoprostone—Muscle spasms—Lisinopril—systemic scleroderma	0.000435	0.00247	CcSEcCtD
Dinoprostone—Rash—Pentoxifylline—systemic scleroderma	0.000434	0.00247	CcSEcCtD
Dinoprostone—Hypertension—Mycophenolic acid—systemic scleroderma	0.000434	0.00246	CcSEcCtD
Dinoprostone—Dermatitis—Pentoxifylline—systemic scleroderma	0.000433	0.00246	CcSEcCtD
Dinoprostone—Headache—Pentoxifylline—systemic scleroderma	0.000431	0.00245	CcSEcCtD
Dinoprostone—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00043	0.00244	CcSEcCtD
Dinoprostone—Chest pain—Mycophenolic acid—systemic scleroderma	0.000427	0.00243	CcSEcCtD
Dinoprostone—Myalgia—Mycophenolic acid—systemic scleroderma	0.000427	0.00243	CcSEcCtD
Dinoprostone—Arthralgia—Mycophenolic acid—systemic scleroderma	0.000427	0.00243	CcSEcCtD
Dinoprostone—Vision blurred—Lisinopril—systemic scleroderma	0.000426	0.00242	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Captopril—systemic scleroderma	0.000426	0.00242	CcSEcCtD
Dinoprostone—Asthenia—Mometasone—systemic scleroderma	0.000426	0.00242	CcSEcCtD
Dinoprostone—Hypotension—Azathioprine—systemic scleroderma	0.000425	0.00242	CcSEcCtD
Dinoprostone—Cardiac arrest—Prednisone—systemic scleroderma	0.000424	0.00241	CcSEcCtD
Dinoprostone—Tremor—Lisinopril—systemic scleroderma	0.000424	0.00241	CcSEcCtD
Dinoprostone—Tachycardia—Leflunomide—systemic scleroderma	0.000419	0.00238	CcSEcCtD
Dinoprostone—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000415	0.00236	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000414	0.00236	CcSEcCtD
Dinoprostone—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.000413	0.00235	CcSEcCtD
Dinoprostone—Body temperature increased—Captopril—systemic scleroderma	0.000412	0.00234	CcSEcCtD
Dinoprostone—Abdominal pain—Captopril—systemic scleroderma	0.000412	0.00234	CcSEcCtD
Dinoprostone—Nausea—Pentoxifylline—systemic scleroderma	0.000409	0.00232	CcSEcCtD
Dinoprostone—Chills—Mycophenolate mofetil—systemic scleroderma	0.000408	0.00232	CcSEcCtD
Dinoprostone—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.000407	0.00231	CcSEcCtD
Dinoprostone—Diarrhoea—Mometasone—systemic scleroderma	0.000406	0.00231	CcSEcCtD
Dinoprostone—Syncope—Lisinopril—systemic scleroderma	0.000406	0.00231	CcSEcCtD
Dinoprostone—Shock—Mycophenolic acid—systemic scleroderma	0.000403	0.00229	CcSEcCtD
Dinoprostone—Hypotension—Leflunomide—systemic scleroderma	0.000401	0.00228	CcSEcCtD
Dinoprostone—Tachycardia—Mycophenolic acid—systemic scleroderma	0.0004	0.00227	CcSEcCtD
Dinoprostone—Loss of consciousness—Lisinopril—systemic scleroderma	0.000398	0.00226	CcSEcCtD
Dinoprostone—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000396	0.00225	CcSEcCtD
Dinoprostone—Cough—Lisinopril—systemic scleroderma	0.000395	0.00224	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000391	0.00222	CcSEcCtD
Dinoprostone—Tension—Mycophenolate mofetil—systemic scleroderma	0.000389	0.00221	CcSEcCtD
Dinoprostone—Paraesthesia—Leflunomide—systemic scleroderma	0.000386	0.00219	CcSEcCtD
Dinoprostone—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.000385	0.00219	CcSEcCtD
Dinoprostone—Arthralgia—Lisinopril—systemic scleroderma	0.000385	0.00219	CcSEcCtD
Dinoprostone—Chest pain—Lisinopril—systemic scleroderma	0.000385	0.00219	CcSEcCtD
Dinoprostone—Myalgia—Lisinopril—systemic scleroderma	0.000385	0.00219	CcSEcCtD
Dinoprostone—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000383	0.00218	CcSEcCtD
Dinoprostone—Dyspnoea—Leflunomide—systemic scleroderma	0.000383	0.00218	CcSEcCtD
Dinoprostone—Hypotension—Mycophenolic acid—systemic scleroderma	0.000383	0.00218	CcSEcCtD
Dinoprostone—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000381	0.00217	CcSEcCtD
Dinoprostone—Vomiting—Mometasone—systemic scleroderma	0.000377	0.00214	CcSEcCtD
Dinoprostone—Sweating increased—Prednisone—systemic scleroderma	0.000376	0.00213	CcSEcCtD
Dinoprostone—Rash—Mometasone—systemic scleroderma	0.000374	0.00213	CcSEcCtD
Dinoprostone—Asthenia—Captopril—systemic scleroderma	0.000374	0.00213	CcSEcCtD
Dinoprostone—Dermatitis—Mometasone—systemic scleroderma	0.000374	0.00213	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000373	0.00212	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000372	0.00211	CcSEcCtD
Dinoprostone—Headache—Mometasone—systemic scleroderma	0.000372	0.00211	CcSEcCtD
Dinoprostone—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000371	0.00211	CcSEcCtD
Dinoprostone—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000369	0.0021	CcSEcCtD
Dinoprostone—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000368	0.00209	CcSEcCtD
Dinoprostone—Pain—Leflunomide—systemic scleroderma	0.000367	0.00209	CcSEcCtD
Dinoprostone—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000365	0.00208	CcSEcCtD
Dinoprostone—Shock—Lisinopril—systemic scleroderma	0.000363	0.00206	CcSEcCtD
Dinoprostone—Tachycardia—Lisinopril—systemic scleroderma	0.00036	0.00205	CcSEcCtD
Dinoprostone—Abdominal pain—Azathioprine—systemic scleroderma	0.00036	0.00204	CcSEcCtD
Dinoprostone—Body temperature increased—Azathioprine—systemic scleroderma	0.00036	0.00204	CcSEcCtD
Dinoprostone—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000357	0.00203	CcSEcCtD
Dinoprostone—Diarrhoea—Captopril—systemic scleroderma	0.000357	0.00203	CcSEcCtD
Dinoprostone—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000355	0.00202	CcSEcCtD
Dinoprostone—Nausea—Mometasone—systemic scleroderma	0.000352	0.002	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000351	0.002	CcSEcCtD
Dinoprostone—Pain—Mycophenolic acid—systemic scleroderma	0.00035	0.00199	CcSEcCtD
Dinoprostone—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000348	0.00198	CcSEcCtD
Dinoprostone—Cough—Mycophenolate mofetil—systemic scleroderma	0.000346	0.00197	CcSEcCtD
Dinoprostone—Hypotension—Lisinopril—systemic scleroderma	0.000345	0.00196	CcSEcCtD
Dinoprostone—Dizziness—Captopril—systemic scleroderma	0.000345	0.00196	CcSEcCtD
Dinoprostone—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000342	0.00194	CcSEcCtD
Dinoprostone—Abdominal pain—Leflunomide—systemic scleroderma	0.00034	0.00193	CcSEcCtD
Dinoprostone—Body temperature increased—Leflunomide—systemic scleroderma	0.00034	0.00193	CcSEcCtD
Dinoprostone—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000339	0.00193	CcSEcCtD
Dinoprostone—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000337	0.00192	CcSEcCtD
Dinoprostone—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000337	0.00192	CcSEcCtD
Dinoprostone—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000337	0.00192	CcSEcCtD
Dinoprostone—Myocardial infarction—Prednisone—systemic scleroderma	0.000337	0.00192	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000336	0.00191	CcSEcCtD
Dinoprostone—Hypersensitivity—Azathioprine—systemic scleroderma	0.000335	0.00191	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000335	0.0019	CcSEcCtD
Dinoprostone—Paraesthesia—Lisinopril—systemic scleroderma	0.000331	0.00188	CcSEcCtD
Dinoprostone—Vomiting—Captopril—systemic scleroderma	0.000331	0.00188	CcSEcCtD
Dinoprostone—Dyspnoea—Lisinopril—systemic scleroderma	0.000329	0.00187	CcSEcCtD
Dinoprostone—Rash—Captopril—systemic scleroderma	0.000329	0.00187	CcSEcCtD
Dinoprostone—Dermatitis—Captopril—systemic scleroderma	0.000328	0.00187	CcSEcCtD
Dinoprostone—Headache—Captopril—systemic scleroderma	0.000327	0.00186	CcSEcCtD
Dinoprostone—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000324	0.00184	CcSEcCtD
Dinoprostone—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000324	0.00184	CcSEcCtD
Dinoprostone—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000323	0.00184	CcSEcCtD
Dinoprostone—Asthma—Methotrexate—systemic scleroderma	0.000322	0.00183	CcSEcCtD
Dinoprostone—Shock—Mycophenolate mofetil—systemic scleroderma	0.000318	0.00181	CcSEcCtD
Dinoprostone—Hypersensitivity—Leflunomide—systemic scleroderma	0.000316	0.0018	CcSEcCtD
Dinoprostone—Pain—Lisinopril—systemic scleroderma	0.000316	0.00179	CcSEcCtD
Dinoprostone—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000316	0.00179	CcSEcCtD
Dinoprostone—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000313	0.00178	CcSEcCtD
Dinoprostone—Diarrhoea—Azathioprine—systemic scleroderma	0.000311	0.00177	CcSEcCtD
Dinoprostone—Nausea—Captopril—systemic scleroderma	0.00031	0.00176	CcSEcCtD
Dinoprostone—Asthenia—Leflunomide—systemic scleroderma	0.000308	0.00175	CcSEcCtD
Dinoprostone—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000302	0.00172	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000302	0.00172	CcSEcCtD
Dinoprostone—Dizziness—Azathioprine—systemic scleroderma	0.000301	0.00171	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000295	0.00168	CcSEcCtD
Dinoprostone—Asthenia—Mycophenolic acid—systemic scleroderma	0.000294	0.00167	CcSEcCtD
Dinoprostone—Diarrhoea—Leflunomide—systemic scleroderma	0.000294	0.00167	CcSEcCtD
Dinoprostone—Abdominal pain—Lisinopril—systemic scleroderma	0.000292	0.00166	CcSEcCtD
Dinoprostone—Body temperature increased—Lisinopril—systemic scleroderma	0.000292	0.00166	CcSEcCtD
Dinoprostone—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00029	0.00165	CcSEcCtD
Dinoprostone—Vomiting—Azathioprine—systemic scleroderma	0.000289	0.00164	CcSEcCtD
Dinoprostone—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000288	0.00164	CcSEcCtD
Dinoprostone—Rash—Azathioprine—systemic scleroderma	0.000287	0.00163	CcSEcCtD
Dinoprostone—Dermatitis—Azathioprine—systemic scleroderma	0.000287	0.00163	CcSEcCtD
Dinoprostone—Flushing—Prednisone—systemic scleroderma	0.000286	0.00163	CcSEcCtD
Dinoprostone—Headache—Azathioprine—systemic scleroderma	0.000285	0.00162	CcSEcCtD
Dinoprostone—Dizziness—Leflunomide—systemic scleroderma	0.000284	0.00161	CcSEcCtD
Dinoprostone—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00028	0.00159	CcSEcCtD
Dinoprostone—Angiopathy—Prednisone—systemic scleroderma	0.00028	0.00159	CcSEcCtD
Dinoprostone—Immune system disorder—Prednisone—systemic scleroderma	0.000279	0.00158	CcSEcCtD
Dinoprostone—Pain—Mycophenolate mofetil—systemic scleroderma	0.000277	0.00157	CcSEcCtD
Dinoprostone—Arrhythmia—Prednisone—systemic scleroderma	0.000276	0.00157	CcSEcCtD
Dinoprostone—Vomiting—Leflunomide—systemic scleroderma	0.000273	0.00155	CcSEcCtD
Dinoprostone—Hypersensitivity—Lisinopril—systemic scleroderma	0.000272	0.00155	CcSEcCtD
Dinoprostone—Dizziness—Mycophenolic acid—systemic scleroderma	0.000271	0.00154	CcSEcCtD
Dinoprostone—Rash—Leflunomide—systemic scleroderma	0.000271	0.00154	CcSEcCtD
Dinoprostone—Dermatitis—Leflunomide—systemic scleroderma	0.000271	0.00154	CcSEcCtD
Dinoprostone—Nausea—Azathioprine—systemic scleroderma	0.00027	0.00154	CcSEcCtD
Dinoprostone—Headache—Leflunomide—systemic scleroderma	0.000269	0.00153	CcSEcCtD
Dinoprostone—Asthenia—Lisinopril—systemic scleroderma	0.000265	0.00151	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000264	0.0015	CcSEcCtD
Dinoprostone—Vomiting—Mycophenolic acid—systemic scleroderma	0.000261	0.00148	CcSEcCtD
Dinoprostone—Rash—Mycophenolic acid—systemic scleroderma	0.000258	0.00147	CcSEcCtD
Dinoprostone—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000258	0.00147	CcSEcCtD
Dinoprostone—Headache—Mycophenolic acid—systemic scleroderma	0.000257	0.00146	CcSEcCtD
Dinoprostone—Pharyngitis—Methotrexate—systemic scleroderma	0.000256	0.00145	CcSEcCtD
Dinoprostone—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000256	0.00145	CcSEcCtD
Dinoprostone—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000256	0.00145	CcSEcCtD
Dinoprostone—Nausea—Leflunomide—systemic scleroderma	0.000255	0.00145	CcSEcCtD
Dinoprostone—Vision blurred—Prednisone—systemic scleroderma	0.000253	0.00144	CcSEcCtD
Dinoprostone—Diarrhoea—Lisinopril—systemic scleroderma	0.000253	0.00144	CcSEcCtD
Dinoprostone—Dizziness—Lisinopril—systemic scleroderma	0.000244	0.00139	CcSEcCtD
Dinoprostone—Nausea—Mycophenolic acid—systemic scleroderma	0.000243	0.00138	CcSEcCtD
Dinoprostone—Syncope—Prednisone—systemic scleroderma	0.000241	0.00137	CcSEcCtD
Dinoprostone—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000238	0.00135	CcSEcCtD
Dinoprostone—Loss of consciousness—Prednisone—systemic scleroderma	0.000236	0.00134	CcSEcCtD
Dinoprostone—Vomiting—Lisinopril—systemic scleroderma	0.000235	0.00133	CcSEcCtD
Dinoprostone—Angiopathy—Methotrexate—systemic scleroderma	0.000234	0.00133	CcSEcCtD
Dinoprostone—Immune system disorder—Methotrexate—systemic scleroderma	0.000233	0.00132	CcSEcCtD
Dinoprostone—Rash—Lisinopril—systemic scleroderma	0.000233	0.00132	CcSEcCtD
Dinoprostone—Dermatitis—Lisinopril—systemic scleroderma	0.000233	0.00132	CcSEcCtD
Dinoprostone—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000232	0.00132	CcSEcCtD
Dinoprostone—Hypertension—Prednisone—systemic scleroderma	0.000232	0.00132	CcSEcCtD
Dinoprostone—Chills—Methotrexate—systemic scleroderma	0.000231	0.00132	CcSEcCtD
Dinoprostone—Headache—Lisinopril—systemic scleroderma	0.000231	0.00131	CcSEcCtD
Dinoprostone—Arthralgia—Prednisone—systemic scleroderma	0.000229	0.0013	CcSEcCtD
Dinoprostone—Myalgia—Prednisone—systemic scleroderma	0.000229	0.0013	CcSEcCtD
Dinoprostone—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000221	0.00126	CcSEcCtD
Dinoprostone—Nausea—Lisinopril—systemic scleroderma	0.000219	0.00125	CcSEcCtD
Dinoprostone—Anaphylactic shock—Prednisone—systemic scleroderma	0.000219	0.00125	CcSEcCtD
Dinoprostone—Back pain—Methotrexate—systemic scleroderma	0.000217	0.00123	CcSEcCtD
Dinoprostone—Shock—Prednisone—systemic scleroderma	0.000216	0.00123	CcSEcCtD
Dinoprostone—Tachycardia—Prednisone—systemic scleroderma	0.000214	0.00122	CcSEcCtD
Dinoprostone—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000214	0.00122	CcSEcCtD
Dinoprostone—Hyperhidrosis—Prednisone—systemic scleroderma	0.000212	0.0012	CcSEcCtD
Dinoprostone—Vision blurred—Methotrexate—systemic scleroderma	0.000212	0.0012	CcSEcCtD
Dinoprostone—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000206	0.00117	CcSEcCtD
Dinoprostone—Rash—Mycophenolate mofetil—systemic scleroderma	0.000204	0.00116	CcSEcCtD
Dinoprostone—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000204	0.00116	CcSEcCtD
Dinoprostone—Headache—Mycophenolate mofetil—systemic scleroderma	0.000203	0.00115	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.0002	0.00114	CcSEcCtD
Dinoprostone—Paraesthesia—Prednisone—systemic scleroderma	0.000197	0.00112	CcSEcCtD
Dinoprostone—Cough—Methotrexate—systemic scleroderma	0.000196	0.00111	CcSEcCtD
Dinoprostone—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000192	0.00109	CcSEcCtD
Dinoprostone—Chest pain—Methotrexate—systemic scleroderma	0.000191	0.00109	CcSEcCtD
Dinoprostone—Arthralgia—Methotrexate—systemic scleroderma	0.000191	0.00109	CcSEcCtD
Dinoprostone—Myalgia—Methotrexate—systemic scleroderma	0.000191	0.00109	CcSEcCtD
Dinoprostone—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000183	0.00104	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000179	0.00102	CcSEcCtD
Dinoprostone—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000177	0.00101	CcSEcCtD
Dinoprostone—Body temperature increased—Prednisone—systemic scleroderma	0.000173	0.000985	CcSEcCtD
Dinoprostone—Abdominal pain—Prednisone—systemic scleroderma	0.000173	0.000985	CcSEcCtD
Dinoprostone—Hypotension—Methotrexate—systemic scleroderma	0.000171	0.000973	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000167	0.000949	CcSEcCtD
Dinoprostone—Paraesthesia—Methotrexate—systemic scleroderma	0.000165	0.000935	CcSEcCtD
Dinoprostone—Dyspnoea—Methotrexate—systemic scleroderma	0.000163	0.000929	CcSEcCtD
Dinoprostone—Hypersensitivity—Prednisone—systemic scleroderma	0.000162	0.000918	CcSEcCtD
Dinoprostone—Asthenia—Prednisone—systemic scleroderma	0.000157	0.000894	CcSEcCtD
Dinoprostone—Pain—Methotrexate—systemic scleroderma	0.000157	0.000891	CcSEcCtD
Dinoprostone—Diarrhoea—Prednisone—systemic scleroderma	0.00015	0.000853	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.00015	0.000852	CcSEcCtD
Dinoprostone—Dizziness—Prednisone—systemic scleroderma	0.000145	0.000824	CcSEcCtD
Dinoprostone—Body temperature increased—Methotrexate—systemic scleroderma	0.000145	0.000823	CcSEcCtD
Dinoprostone—Abdominal pain—Methotrexate—systemic scleroderma	0.000145	0.000823	CcSEcCtD
Dinoprostone—Vomiting—Prednisone—systemic scleroderma	0.000139	0.000792	CcSEcCtD
Dinoprostone—Rash—Prednisone—systemic scleroderma	0.000138	0.000786	CcSEcCtD
Dinoprostone—Dermatitis—Prednisone—systemic scleroderma	0.000138	0.000785	CcSEcCtD
Dinoprostone—Headache—Prednisone—systemic scleroderma	0.000137	0.000781	CcSEcCtD
Dinoprostone—Hypersensitivity—Methotrexate—systemic scleroderma	0.000135	0.000767	CcSEcCtD
Dinoprostone—Asthenia—Methotrexate—systemic scleroderma	0.000131	0.000747	CcSEcCtD
Dinoprostone—Nausea—Prednisone—systemic scleroderma	0.00013	0.00074	CcSEcCtD
Dinoprostone—Diarrhoea—Methotrexate—systemic scleroderma	0.000125	0.000713	CcSEcCtD
Dinoprostone—Dizziness—Methotrexate—systemic scleroderma	0.000121	0.000689	CcSEcCtD
Dinoprostone—Vomiting—Methotrexate—systemic scleroderma	0.000116	0.000662	CcSEcCtD
Dinoprostone—Rash—Methotrexate—systemic scleroderma	0.000116	0.000657	CcSEcCtD
Dinoprostone—Dermatitis—Methotrexate—systemic scleroderma	0.000115	0.000656	CcSEcCtD
Dinoprostone—Headache—Methotrexate—systemic scleroderma	0.000115	0.000652	CcSEcCtD
Dinoprostone—Nausea—Methotrexate—systemic scleroderma	0.000109	0.000619	CcSEcCtD
